These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10588461)

  • 1. Increased platelet surface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia.
    Griesshammer M; Beneke H; Nussbaumer B; Grünewald M; Bangerter M; Bergmann L
    Thromb Res; 1999 Nov; 96(3):191-6. PubMed ID: 10588461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation.
    Yip HK; Chen SS; Liu JS; Chang HW; Kao YF; Lan MY; Chang YY; Lai SL; Chen WH; Chen MC
    Stroke; 2004 Jul; 35(7):1683-7. PubMed ID: 15155956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia.
    Dill V; Kirmes K; Han J; Klug M; Rosenbaum M; Viggiani G; von Scheidt M; List M; Herhaus P; Ruland J; Bassermann F; Laugwitz KL; Götze KS; Jost PJ; Jilg S; Bloxham CJ; Raake PWJ; Bernlochner I; Bongiovanni D
    Platelets; 2024 Dec; 35(1):2358244. PubMed ID: 38845541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system.
    Macey MG; Carty E; Webb L; Chapman ES; Zelmanovic D; Okrongly D; Rampton DS; Newland AC
    Cytometry; 1999 Oct; 38(5):250-5. PubMed ID: 10516612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
    Choudhury A; Chung I; Blann AD; Lip GY
    J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microembolic signals on transcranial Doppler ultrasound are correlated with platelet activation markers, but not with platelet-leukocyte associates: a study in patients with acute stroke and in patients with asymptomatic carotid stenosis.
    Ritter MA; Jurk K; Schriek C; Nabavi DG; Droste DW; Kehrel BE; Bernd Ringelstein E
    Neurol Res; 2009 Feb; 31(1):11-6. PubMed ID: 18768115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
    Ito H; Miyakoda G; Mori T
    Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia.
    Yıldırım ZK; Orhan MF; Büyükavcı M
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients.
    Chandler AB; Earhart AD; Speich HE; Kueter TJ; Hansen J; White MM; Jennings LK
    Thromb Res; 2010 Jan; 125(1):44-52. PubMed ID: 19487018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hormone replacement therapy on Ca2+ mobilization and P-selectin (CD62P) expression in platelets examined under flow cytometry.
    García-Martínez MC; Labiós M; Hermenegildo C; Tarín JJ; O'Connor E; Cano A
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):1-8. PubMed ID: 15166936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease.
    Meyer A; Weithaeuser A; Steffens D; Bobbert P; Hassanein A; Ayral Y; Schultheiss HP; Rauch U
    Cardiovasc Revasc Med; 2016; 17(3):169-75. PubMed ID: 27157293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulators of intraplatelet calcium concentration affect the binding of thrombospondin to blood platelets in healthy donors and patients with type 2 diabetes mellitus.
    Wieclawska B; Rozalski M; Trojanowski Z; Watala C
    Eur J Haematol; 2001 Jun; 66(6):396-403. PubMed ID: 11488939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment.
    Reményi G; Szász R; Debreceni IB; Szarvas M; Batár P; Nagy B; Kappelmayer J; Udvardy M
    Platelets; 2013; 24(6):486-92. PubMed ID: 23216455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
    Nkambule BB; Davison G; Ipp H
    Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.
    Cella G; Marchetti M; Vianello F; Panova-Noeva M; Vignoli A; Russo L; Barbui T; Falanga A
    Thromb Haemost; 2010 Jul; 104(1):151-6. PubMed ID: 20431848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia.
    Tran JQD; Pedersen OH; Larsen ML; Grove EL; Kristensen SD; Hvas AM; Nissen PH
    Platelets; 2020; 31(3):365-372. PubMed ID: 31240987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.